Connect Biopharma Holdings Ltd (CNTB)vsRevolution Medicines Inc (RVMD)
CNTB
Connect Biopharma Holdings Ltd
$2.04
-0.97%
HEALTHCARE · Cap: $128.47M
RVMD
Revolution Medicines Inc
$203.77
+0.21%
HEALTHCARE · Cap: $44.44B
Smart Verdict
WallStSmart Research — data-driven comparison
Connect Biopharma Holdings Ltd generates 298% more annual revenue ($2.95M vs $742,000). RVMD leads profitability with a 0.0% profit margin vs 0.0%. CNTB earns a higher WallStSmart Score of 30/100 (F).
CNTB
Avoid30
out of 100
Grade: F
RVMD
Avoid24
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 5667.0% year-over-year
Conservative balance sheet, low leverage
Conservative balance sheet, low leverage
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Weak financial health signals
Trading at 16.8x book value
0.0% earnings growth
0.0% margin — thin
Operating margin of 0.0%
Comparative Analysis Report
WallStSmart ResearchBull Case : CNTB
The strongest argument for CNTB centers on Revenue Growth, Debt/Equity. Revenue growth of 5667.0% demonstrates continued momentum.
Bull Case : RVMD
The strongest argument for RVMD centers on Debt/Equity.
Bear Case : CNTB
The primary concerns for CNTB are EPS Growth, Market Cap, Profit Margin.
Bear Case : RVMD
The primary concerns for RVMD are Price/Book, EPS Growth, Profit Margin.
Key Dynamics to Monitor
CNTB profiles as a hypergrowth stock while RVMD is a value play — different risk/reward profiles.
RVMD carries more volatility with a beta of 1.41 — expect wider price swings.
CNTB is growing revenue faster at 5667.0% — sustainability is the question.
CNTB generates stronger free cash flow (-32M), providing more financial flexibility.
Bottom Line
CNTB scores higher overall (30/100 vs 24/100) and 5667.0% revenue growth. Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Connect Biopharma Holdings Ltd
HEALTHCARE · BIOTECHNOLOGY · USA
Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, is focused on the discovery and development of immune modulators for the treatment of severe autoimmune diseases and inflammation. The company is headquartered in Taicang, China.
Revolution Medicines Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted cancers. The company is headquartered in Redwood City, California.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?